Association of DM genes in systemic sclerosis is secondary to the association with HLA genes

Scandinavian Journal of Rheumatology

Volumn 26, Issue 3, 1997, Pages 174-179

  Takeuchi, F ^a   Takizawa, K ^a   Nabeta, H ^a   Kuwata, S ^a   Ito, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anti Scl 70 antibody; Diffuse scleroderma; DMA; DMB; HLA DR; Japanese; Polymorphism; Systemic sclerosis

Indexed keywords

HLA DR ANTIGEN;

ANTIBODY DETECTION; ARTICLE; DNA POLYMORPHISM; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; HLA SYSTEM; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCLERODERMA; SYSTEMIC SCLEROSIS;

EID: 0030752860     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749709065677     Document Type: Article

References (23)

1. Masi AT, Rodman GP, Medsger TA Jr, Altman RD, D'Angelo WA, Fries JF, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-90.
2. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15: 202-5.
3. Reveille JD, Owerbach D, Goldstein R, Moreda R, Isern RA, Arnett FC. Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma). J Clin Invest 1992;89:1208-13.
4. Reveille JD, Durban E, MacLeod-St. Clair MJ, Goldstein R, Moreda R, et al. Association of amino acids sequences in the HLA-DQBl first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest 1992;90:973-80.
5. Takeuchi F, Nakano K, Yamada H, Hong GH, Nabeta H, Yoshida A, et al. Association of HLA-DR with progressive systemic sclerosis in Japanese. J Rheumatol 1994;21:857-63.
6. Kuwana M, Kaburaki J, Okamoto Y, Inoko H, Tsuji K. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest 1993;92:1296-301.
7. Black CM, Welsh KI, Maddison PJ, Jayson MI, Bernstein RM. HLA antigens, autoantibodies and clinical subsets in scleroderma. Br J Rheumatol 1984;23:267-71.
8. Briggs DC, Welsh K, Pereira RS, Black CM. A strong association between null alleles at the C4A locus in the major histocompatibility complex and systemic sclerosis. Arthritis Rheum 1986;29:1274-7.
9. Mollenhauer E, Schmidt R, Heinrichs M, Rittner C. Scleroderma: possible significance of silent alleles at the C4B locus. Arthritis Rheum 1984;27:711-2.
10. Kelly AP, Monaco JJ, Cho SG, Trowsdale J. A new human HLA class II-related locus, DM. Nature 1991;353:571-3.
11. Ceman S, Rudersdorf RA, Peterson JM, DeMars R. DMA and DMB are the only genes in the class H region of the human MHC needed for class II-associated antigen processing. J Immunol 1995;30:2545-56.
12. West MA, Lucocq JM, Watts C. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature 1994;369:147-51.
13. Denzin LK, Cresswell P. HLA-DM induces CLIP dissociation from MHC class II α β dimers and facilitates peptide loading Cell 1995;82:155-65.
14. Carrington M, Yeager M, Mann D. Chracterization of HLA-DMB polymorphism. Immunogenetics 1993;38:446-9.
15. Carrington M, Harding A. Sequence analysis of two novel HLA-DMA alleles. Immunogenetics 1994;40:165.
16. Kuwata S, Yanagisawa M, Nakagawa H, Saeki H, Etoh T, Miyamoto M, et al. HLA-DM gene polymorphism in atopic dermatitis. J Allergy Clin Immunol 1996;98:192-200.
17. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239: 487-91.
18. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Bontrop RE, Charron D, et al. Nomenclature for factors of the HLA system. 1995. Tissue Antigens 1995;46:1-18.
19. Tiwari JL, Terasaki PI. HLA and disease association. New York; Springer-Verlag, 1985.
20. Monji T, McCormack AL, Yates JR, Pious D. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants. J Immunol 1994;153:4468-77.
21. Schmid SL, Jackson MR. Making class II presentable. Nature 1994;369:103-4.
22. Hillarby MC, Davies EJ, Donn RP, Grennan DM, Ollier WER. TAP2D is associated with HLA-B44 and DR4 and may contribute to rheumatoid arthritis and Felty's syndrome susceptibility. Clin Exp Rheumatol 1996;14:67-70.
23. Singal DP, Ye M, Qiu X, D'Souza M. Polymorphism in the TAP2 gene and their association with rheumatoid arthritis. Clin Exp Rheumatol 1994;12:29-33.